DHEA supplementation may improve IVF outcome in poor responders: A proposed mechanism

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 168, Issue 1, 2013, Pages 49-53

  Hyman, Jordana H ^a   Margalioth, Ehud J ^a   Rabinowitz, Ron ^a,b   Tsafrir, Avi ^a   Gal, Michael ^a,b   Alerhand, Sarah ^a   Algur, Nurit ^a   Eldar Geva, Talia ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Antral follicle count (AFC); DHEA supplementation; Poor responder

Indexed keywords

CETRORELIX; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; INHIBIN B; PRASTERONE; RECOMBINANT CHORIONIC GONADOTROPIN;

ADULT; ANDROGEN THERAPY; ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; LIVE BIRTH; METAPHASE; OOCYTE; OVARIAN RESERVE; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PATIENT COMPLIANCE; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; STEROIDOGENESIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTI-MULLERIAN HORMONE; DEHYDROEPIANDROSTERONE; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; OVARIAN FOLLICLE; OVULATION INDUCTION; PROSPECTIVE STUDIES;

EID: 84876944139     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2012.12.017     Document Type: Article

References (49)

1. J.M. Jenkins, D.W. Davies, and H. Devonport Comparison of 'poor' responders with 'good' responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization Human Reproduction 6 1991 918 921
2. U. Ulug, I. Ben-Shlomo, and E. Turan Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles Reproductive Biomedicine Online 6 2003 439 443
3. F.J. Broekmans, J. Kwee, and D.J. Hendriks A systematic review of tests predicting ovarian reserve and IVF outcome Human Reproduction Update 12 2006 685 718
4. K. Jayaprakasan, B. Campbell, and J. Hopkisson A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation Fertility and Sterility 93 2008 855 864
5. S. Muttukrishna, H. McGarrigle, and R. Wakim Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG: An International Journal of Obstetrics and Gynaecology 112 2005 1384 1390
6. J. Kwee, R. Schats, and J. McDonnell Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve Fertility and Sterility 90 2008 737 743
7. L.G. Nardo, T.A. Gelbaya, and H. Wilkinson Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization Fertility and Sterility 92 2009 1586 1593
8. R.M. Riggs, E.H. Duran, and M.W. Baker Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age American Journal of Obstetrics and Gynecology 199 2008 202e1 202e8
9. G. Barrenetxea, J.A. Agirregoikoa, and M.R. Jiménez Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles Fertility and Sterility 89 2008 546 553
10. C. Battaglia, M. Salvatori, and N. Maxia Adjuvant l-arginine treatment for in-vitro fertilization in poor responder patients Human Reproduction 14 1999 1690 1697
11. S.J. Fasouliotis, N. Laufer, and S. Sabbagh-Ehrlich Gonadotropin- releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF Journal of Assisted Reproduction and Genetics 20 2003 455 460
12. J.G. Franco Jr., R.L. Baruffi, and A.L. Mauri GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis Reproductive Biomedicine Online 13 2006 618 627
13. J.L. Frattarelli, G.D. McWilliams, and M.J. Hill Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders Fertility and Sterility 89 2008 1113 1117
14. J.A. Garcia-Velasco, L. Moreno, and A. Pacheco The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study Fertility and Sterility 84 2005 82 87
15. M.J. Hill, G.D. McWilliams, and K.A. Miller A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates Fertility and Sterility 91 2009 739 743
16. W.B. Schoolcraft, T. Schlenker, and M. Gee Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol Fertility and Sterility 67 1997 93 97
17. W.B. Schoolcraft, E.S. Surrey, and D.A. Minjarez Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol? Fertility and Sterility 89 2008 151 156
18. E.S. Surrey, J. Bower, and D.M. Hill Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization Fertility and Sterility 69 1998 419 424
19. J.K. Bosdou, C.A. Venetis, and E.M. Kolibianakis The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis Human Reproduction Update 18 2012 127 145
20. Z. Pandian, A.R. McTavish, and L. Aucott Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database of Systematic Reviews 20 2010 CD004379
21. W. Arlt Dehydroepiandrosterone replacement therapy Seminars in Reproductive Medicine 22 2004 379 388
22. Fritz MA, Speroff L. Hormone biosynthesis, metabolism, and mechanism of action (Chapter 2) and Regulation of the menstrual cycle (Chapter 6). In: Clinical gynecologic endocrinology and infertility (eighth edition). Philadephia, PA: Lippincott Williams & Wilkins, 2011. p. 29-104 and 199-242.
23. A.J. Morales, J.J. Nolan, and J.C. Nelson Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age Journal of Clinical Endocrinology and Metabolism 78 1994 1360 1367
24. D.H. Barad, and N. Gleicher Increased oocyte production after treatment with dehydroepiandrosterone Fertility and Sterility 84 2005 756
25. P.R. Casson, M.S. Lindsay, and M.D. Pisarska Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series Human Reproduction 15 2000 2129 2132
26. H.G. van Weering, D.R. Gutknecht, and R. Schats Augmentation of ovarian response by dehydroepiandrosterone Human Reproduction 16 2001 1537 1538
27. D. Barad, and N. Gleicher Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF Human Reproduction 21 2006 2845 2849
28. D. Barad, H. Brill, and N. Gleicher Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function Journal of Assisted Reproduction and Genetics 24 2007 629 634
29. N. Gleicher, and D. Barad The effect of dehydroepiandrosterone on diminished ovarian reserve Human Reproduction 21 S1 2006 i69
30. N. Gleicher, A. Weghofer, and D.H. Barad Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS) Reproductive Biology and Endocrinology 8 2010 140
31. N. Gleicher, A. Weghofer, and D.H. Barad Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation Reproductive Biomedicine Online 21 2010 360 365
32. M. Sönmezer, B. Ozmen, and A.P. Cil Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders Reproductive Biomedicine Online 19 2009 508 513
33. A. Wiser, O. Gonenm, and Y. Ghetlerm Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study Human Reproduction 25 2010 2496 2500
34. N. Gleicher, E. Ryan, and A. Weghofer Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study Reproductive Biology and Endocrinology 7 2009 108
35. N. Gleicher, and D.H. Barad Increased euploid embryos after supplementation with dehydroepiandrosterone (DHEA) in women with premature ovarian aging Fertility and Sterility 88 S1 2007 S232
36. N. Gleicher, and D.H. Barad Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR) Reproductive Biology and Endocrinology 9 2011 67
37. K. Yakin, and B. Urman DHEA as a miracle drug in the treatment of poor responders: hype or hope? Human Reproduction 26 2011 1941 1944
38. P.R. Casson, N. Santoro, and K. Elkind-Hirsch Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial Fertility and Sterility 70 1998 107 110
39. R.V. Haning Jr., R.J. Hackett, and C.A. Flood Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins Journal of Clinical Endocrinology and Metabolism 76 1993 1301 1307
40. G. Fried, K. Remaeus, and J. Harlin Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization Journal of Assisted Reproduction and Genetics 20 2003 167 176
41. C. Weenen, J.S. Laven, and A.R. von Bergh Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Molecular Human Reproduction 10 2004 77 83
42. P. Kumanov, K.C. Nandipati, and A. Tomova Significance of inhibin in reproductive pathophysiology and current clinical applications Reproductive Biomedicine Online 10 2005 786 812
43. C.V. Steer, C.L. Mills, and S.L. Tan The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer program Human Reproduction 7 1992 117 119
44. T. Eldar-Geva, E. Zylber-Haran, and R. Babayof Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist. GnRH-antagonist/HCG or long protocol ovarian stimulation Reproductive Biomedicine Online 14 2007 148 154
45. G.J. Scheffer, F.J. Broekmans, and L.F. Bancsi Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts Ultrasound in Obstetrics and Gynecology 20 2002 270 275
46. M.D. Wittenberger, R.J. Hagerman, and S.L. Sherman The FMR1 premutation and reproduction Fertility and Sterility 87 2007 456 465
47. A. Tsafrir, G. Altarescu, and E. Margalioth PGD for fragile X syndrome: ovarian function is the main determinant of success Human Reproduction 25 2010 2629 2636
48. B. Kumbak, U. Ulug, and B. Erzik Early clinical pregnancy loss rate in poor responder patients does not change compared to age-matched normoresponders Fertility and Sterility 91 2009 106 109
49. L. Mamas, and E. Mamas Premature ovarian failure dehydroepiandrosterone Fertility and Sterility 91 2009 644 646